Heterogeneity in cognitive functioning among patients with bipolar disorder

Journal of Affective Disorders

Volumn 109, Issue 1-2, 2008, Pages 149-156

  Martino, Diego J ^a   Strejilevich, Sergio A ^a   Scápola, María ^a   Igoa, Ana ^a   Marengo, Eliana ^a   Ais, Ezequiel D ^a   Perinot, Lila ^a  

^a Institute of Neurosciences   (Argentina)

Author keywords

Cognitive reserve; Neuropsychology; Obstetric complications; Premorbid IQ

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; FLUOXETINE; LAMOTRIGINE; LITHIUM CARBONATE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE;

ADULT; APTITUDE TEST; ARTICLE; BIPOLAR DISORDER; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LABOR COMPLICATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SAMPLE SIZE;

ADOLESCENT; ADULT; BIPOLAR DISORDER; COGNITION DISORDERS; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 43949115532     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.12.232     Document Type: Article

References (38)

1. Alexander G., Furey M., Grady C., Pietrini P., Brady D., Mentis M., and Schapiro M. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am. J. Psychiatry 154 (1997) 165-172
2. Altshuler L., Ventura J., van Gorp W., Green M., Theberge D., and Mintz J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol. Psychiatry 56 8 (2004) 560-569
3. Barnett J., Salmond C., Jones P., and Sahakian B. Cognitive reserve in neuropsychiatry. Psychol. Med. 36 (2006) 1053-1064
4. Benton A., Hamsher K., and Sivan A. Multilingual Aphasia Examination. third ed. (1983), AJA Associates, Iowa
5. Clark L., Iversen S., and Goodwin G. Sustained attention deficit in bipolar disorder. Br. J. Psychiatry 180 (2002) 313-319
6. Coryell W., Turvey C., Endicott J., Leon A., Mueller T., Solomon D., and Keller M. Bipolar I affective disorder: predictors of outcome after 15 years. J. Affect. Disord. 50 2-3 (1998) 109-116
7. Daban C., Martinez-Arán A., Torrent C., Tabaréz-Seisdedos R., Balanza-Martinez V., Salazar-Fraile J., Selva-Vera G., and Vieta E. Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother. Psychosom. 75 2 (2006) 72-84
8. Dickerson F., Boronow J., Stallings G., Origoni A., Cole S., and Yolken R. Association between cognitive functioning and employment status of persons with bipolar disorder. Psychiatr. Serv. 55 (2004) 54-58
9. Dickerson F., Boronow J., Stallings G., Origoni A., Cole S., and Yolken R. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status. Psychiatr. Res. 129 (2004) 45-53
10. Dickerson F., Boronow J., Stallings G., Origoni A., Cole S., Leister F., Krivogorsky B., and Yolken R. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder. Bipolar. Disord. 8 2 (2006) 124-132
11. Donaldson S., Goldstein L., Landau S., Raymont V., and Frangou S. The Maudsley Bipolar Disorder Project: The effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J. Clin. Psychiatry 64 (2003) 86-93
12. First M., Spitzer R., Gibbon M., and Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinical Version (SCID-CV) (1996), American Psychiatry Press, Washington, DC
13. Frangou S., Donaldson S., Hadjulis M., Landau S., and Goldstein L. The Maudsley bipolar disorder project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol. Psychiatry 58 (2005) 859-864
14. Glahn D., Bearden C., Niendam T., and Escamilla M. The feasibility of neuropsychological endophenotypes in the search for genes associates with bipolar affective disorder. Bipolar Disord. 6 (2004) 171-182
15. Goldberg T., and Harrow M. Consistency of remission and outcome in bipolar and unipolar mood disorders: A 10-year prospective follow-up. J. Affect. Disord. 81 2 (2004) 123-131
16. Goodwin F., and Jamison K. Manic-depressive illness, creativity, and leadership. Manic-depressive illness (1990), Oxford University Press, New York
17. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
18. Heaton R. Wisconsin Card Sorting Test. Psychological Assesment Resources, Odessa, FL (1981)
19. Huxley N., and Baldessarini R.J. Disability and its treatment in bipolar disorder patients. Bipolar Disord. 9 1-2 (2007) 183-196
20. Kaplan E., Goodglass H., and Weintraub S. The Boston Naming Test. second ed. (1983), Leo & Febliger, Philadelphia
21. Kusznir A., Cooke R., and Young L. The correlates of community functioning in patients with bipolar disorder. J. Affect. Disord. 61 1-2 (2000) 81-85
22. Lewis S., Owen M., and Murray R. Obstetric complications and schizophrenia: methodology and mechanism. Schizophrenia: Scientific Progress (1989), Oxford University Press, New York
23. Lezak M. Neuropsychological assessment (1995), Oxford University Press, New York
24. Martinez-Arán A., Vieta E., Reinares M., Colom F., Torrent C., Sanchez-Moreno J., Benabarre A., Goikolea J., Comes M., and Salamero M. Cognitive function across manic or hippomanic, depressed, and euthymic states in bipolar disorder. Am. J. Psychiatry 161 (2004) 262-270
25. Martino D., Igoa A., Ais E., Marengo E., Scápola M., Perinot L., and Strejilevich S. Cognitive subtypes in bipolar disorders. Fifth European Stanley Conference on Bipolar Disorder, Barcelona, Spain (2006)
26. Peralta V., and Cuesta M. Escala Clínica de Intensidad, Frecuencia y Duración del Tratamiento Psicofarmacológico (Escala IFD). Virgen del Camino Hospital, Pamplona, Spain (2002)
27. Quraishi S., and Frangou S. Neuropsychology of bipolar disorder: a review. J. Affect. Disord. 72 (2002) 209-226
28. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Mot. Skills 8 (1958) 271-276
29. Robinson L., and Ferrier I. Evolution of cognitive impairments in bipolar disorder: A systematic review of cross-sectional evidence. Bipolar Disord. 8 (2006) 103-116
30. Robinson L., Thompson J., Gallagher P., Goswami U., Young A., Ferrier I., and Moore P. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J. Affect. Disord. 93 (2006) 105-115
31. Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 7 (1993) 273-295
32. Signoret J., and Whiteley A. A memory battery scale. Int. Neuropsychol. Soc. Bull. (1979) 2-26
33. Torrent C., Martinez-Arán A., Daban C., Sanchez-Moreno J., Comes M., Goikolea J., Salamero M., and Vieta E. Cognitive impairment in bipolar II disorder. Br. J. Psychiatry 189 (2006) 254-259
34. van Gorp W., Altshuler L., Theberge D., Wilkins J., and Dixon W. Cognitive impairments in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch. Gen. Psychiatry 55 (1998) 41-46
35. Wechsler D. Wechsler Adult Intelligence Scale-Revised (1955), Psychological Corporation, Cleveland
36. Young R., Biggs J., Ziegler V., and Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatr. 133 (1978) 429-435
37. Young A., Perret D., and Calder A. Facial Expression of Emotion-Stimuli and Tests (FEEST) (2002), Thames Valley Test Company, Bury St Edmunds
38. Zubieta J., Huguelet P., and Giordani B. Cognitive function in euthymic bipolar I disorder. Psychiatry Res. 102 (2001) 9-20